. Electrophoretic analysis indicates that inactivation of coxsackievirus A13 in low ionic strength solutions is due to the specific loss of the smallest polypeptide VP4 from the virus particle. These results suggest that adsorption of coxsackievirus A13 to receptors on susceptible cells is dependent upon the presence of the capsid protein VP4.
infectious RNA which remains in a state resistant to the action of ribonuclease. However, more than 95% of the virus particles are unable to attach to susceptible cells. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis reveals that coxsackievirus A13 virions contain five structural polypeptides (VP1, VP2a, VP2b, VP3, and VP4). Electrophoretic analysis indicates that inactivation of coxsackievirus A13 in low ionic strength solutions is due to the specific loss of the smallest polypeptide VP4 from the virus particle. These results suggest that adsorption of coxsackievirus A13 to receptors on susceptible cells is dependent upon the presence of the capsid protein VP4.
The inactivation of various picornaviruses by heat (2) , alkaline pH (1, 11, 14) , acid pH (12, 17) , and diethylpyrocarbonate (3) has been widely studied. Furthermore, picornavirus particles that spontaneously elute from susceptible cells are also found to be noninfectious (5, 10) . It has been established that under certain of these conditions inactivation is the result of structural alterations in the viral capsid which lead to the loss of the viral genome (1, 2, 11, 12, 14) . Under other conditions, however, loss or inactivation of viral RNA does not occur. In the latter instances, it has been clearly shown that inactivation is due to the dissociation of the smallest structural polypeptide (VP4) from the capsid and that virions devoid of this polypeptide are non-infectious because they are unable to attach to susceptible cells (2, 3, 5, 12, 17) .
In a previous report from this laboratory, techniques were described for the isolation in solubilized form of receptor activity for several picornaviruses from plasma membranes of suceptible tissues and cells (16) . During the course of this study, it was noted that the hypotonic buffer used in the procedure for assaying the viral binding activity of solubilized receptor rapidly inactivated several serotypes of group A coxsackieviruses. The present communication describes the specific structural alteration in the coxsackievirus capsid which is induced under conditions of low ionic strength and demonstrates that the loss of infectivity of viral particles altered in this manner is not due to the loss or inactivation of viral RNA but is the result of their failure to adsorb to susceptible cells.
MATERIALS AND METHODS
Viruses and cells. The type 1 poliovirus (Mahoney strain) and coxsackievirus A13 (Flores strain) used in this study were 5 AiCi of 3H-labeled uridine per ml was used to label viral RNA. All media containing radioactive isotopes were supplemented with 5 gg of actinomycin D per ml. After incubation, the monolayers were were frozen and thawed five times, and cellular debris was separated from the culture fluid by centrifugation at 900 x g for 10 min. The debris was suspended in a small volume of MEM, sonically treated on ice for 1 min, and then added back to the original culture fluid. Particulate cellular material was removed by a second low-speed centrifugation, and the virus was pelleted by centrifugation in a Spinco 30 rotor at 75,000 x g for 2 h. Virus was suspended in 2 ml of phosphate buffered saline (PBS) and chromatographed on a Sephadex G-75 (Pharmacia) column (25 by 1.5 cm) equilibrated with PBS. The column fractions containing virus were pooled, adjusted to a density of 1.34 g/ml with CsCl, and centrifuged at 179,000 x g for 24 h in a Spinco SW65 rotor. The banded virus was removed through the side of the tube with a syringe and needle, adjusted to a volume of 2 ml with PBS, and rechromatographed on Sephadex G-75. The fractions containing virus were again pooled and constituted the "purified virus preparations" referred to in subsequent experiments.
Plaque assays. Infectious virus was assayed by the method of Holland and McLaren (8) except the overlay medium (0.5% ionagar [Difco] in MEM-CaS-TPB) was supplemented with 30 mM MgCl, to enhance plaque development. A modification of the method of Pagano et al. (18) was used to assay phenol extracts of infectious viral RNA. HeLa cell monolayers were rinsed five times with PBS and pretreated at 25 C for 5 min with 2 ml of PBS containing 500 ,g of DEAE-dextran (Pharmacia) per ml. This solution was removed and 0.2-ml samples of infectious RNA diluted in PBS containing 500 gg of DEAE-dextran per ml were adsorbed to the monolayers for 15 min at 25 C. Inoculum was removed by rinsing three times with PBS, the final rinse being allowed to remain on the monolayers for 15 min. Overlay medium was added, and the cells were incubated at 37 C for 48 h (poliovirus RNA assays) or 96 h (coxsackievirus RNA assays) before staining with 0.5% crystal violet in 20% ethanol.
Inactivation in hypotonic buffer. The standard procedure for inactivation of coxsackievirus A13 in low ionic strength solutions was to dilute purified preparations of virus 1:50 into PBS (control) or into Robert hypotonic buffer (RHB, reference 20) which contains 0.01 M NaCl, 0.01 M Tris (pH 7.2), and 0.001 M MgCl2. Incubation of the RHB dilutions at 37 C for 90 min normally resulted in a 95% or greater loss of viral infectivity, whereas there was essentially no reduction in infectivity in the PBS controls. The PBSand RHB-treated virus was recovered by centrifugation of these dilutions in a Spinco SW65 rotor at 179,000 x g for 2.5 h and the virus pellets were resuspended in 0.5 ml of PBS. These suspensions constitute the "RHB-treated" and "PBS-treated" virus.
Polyacrylamide gel electrophoresis. The procedures used for electrophoresis of viral proteins were essentially the same as those described by Maizel (13) . Samples to be electrophoresed were first exhaustively dialyzed at 4 C against 0.01 M sodium phosphate buffer (pH 7.2). Sodium dodecyl sulfate (SDS), glacial acetic acid, and urea were added to final concentrations of 1%, 10%, and 0.5 M, respectively, and the samples were heated at 37 C for 1 h. The samples were dialyzed for 24 h at 25 C in 0.01 M sodium phosphate buffer containing 0.1% SDS, 0.5 M urea, and 0.1% 2-mercaptoethanol. Immediately before electrophoresis, the samples were placed in a boiling water bath for 2 min, adjusted to 10% and 0.002% with respect to sucrose and bromophenol blue, and 0.1-to 0.2-ml aliquots were immediately applied to gels. The gels (20 x 0.6 cm) contained 10% acrylamide, 0.23% bisacrylamide, 0.1% SDS, and 0.5 M urea in 0.1 M sodium phosphate buffer (pH 7.2). Tray buffer consisted of 0.1% SDS and 0.5 M urea in 0.1 M sodium phosphate buffer (pH 7.2) which was continuously recirculated during the runs. Electrophoresis was conducted at 3 mA/gel for 20 min, then at 4.5 V/cm for an additional 16 h. The gels were fractionated (about 2 mm of gel/fraction) with a Savant autogeldivider directly into scintillation vials containing 0.5 ml of H2O. The vials were held overnight at 25 C, then 10 ml of scintillation fluid was added to each, and radioactivity was counted in a Beckman LS230 scintillation spectrometer. The scintillation fluid contained 5 g of 2,5-diphenyloxazole and 0.15 g of dimethyl 1,4-bis-2-(5-phenyloxazolyl)-benzene in 1.5 liters of a Triton X-100-toluene mixture (1:2, vol/vol). Recovery of radioactivity was greater than 90% in all experiments. In dual-label experiments, the spectrometer settings allowed approximately 10% spillover of "'C counts into the 'H channel and 1% spillover of 3H counts into the 'IC channel.
Reagents. "IC-labeled protein hydrolysate (52 uCi/ mAtom of carbon) and 3H-labeled L-phenylalanine, L-tryptophan, and L-valine (1 Ci/mM, 1 Ci/mM, and 2 Ci/mM, respectively) were purchased from Amersham/Searle, Arlington Heights, Ill. Tritiated uridine (28 Ci/mM) was purchased from New England Nuclear, Boston, Mass. Crystalline ribonuclease was obtained from Worthington Biochemicals Corp., Freehold, N.J.; actinomycin D from Calbiochem, La Jolla, Calif.; and powdered Eagle MEM from Grand Island Biological Co., Grand Island, N.Y. RESULTS
Loss of infectivity of coxsackievirus A13 in hypotonic buffer. The kinetics of inactivation of coxsackievirus A13 in low ionic strength solutions was determined by diluting the virus 1:50 into RHB. A similar dilution in PBS served as the control. The diluted viruses were incubated at 37 C or at 0 C, and at various intervals, samples were removed and assayed for infectious virus by the plaque technique. The results of this experiment ( Fig. 1) show that coxsackievirus A13 is rapidly inactivated in RHB at 37 C, but not at 0 C. Maximum reduction in infectivity of greater than 99% occurs within 30 to 40 min. The residual (<1%) infectious virus found at this time appears to be stable since incubation at 37 C for an additional 3 h had no further effect. However, virus not inactivated by RHB treatment does not represent a population of genetically resistant viruses, because after recultivation they exhibit the same inactivation kinetics as the original preparation. The VOL. 15, 1975 245 (2) , alkaline pH (1, 11, 14) , or acid pH (12) . These conditions lead to the production of a class of subviral particles which are noninfectious because they lack RNA. To determine whether inactivation of coxsackievirus A13 in RHB was the result of a similar mechanism, samples of PBS-and RHB-treated coxsackievirus A13 were divided into four aliquots, and pairs of these aliquots were treated by one of the following experimental procedures (see Table  1 ): (A) one pair was incubated at 37 C for 15 min, and infectious virus was assayed by the plaque technique; (B) one pair was incubated at 37 C for 15 min in the presence of 100 ,ug of RNase per ml, and then infectious virus was assayed; (C) one pair was incubated at 37 C for 15 min, the entire contents of the tube extracted with phenol, and infectious viral RNA assayed by the plaque technique; (D) the final pair was incubated at 37 C for 15 min in the presence of 100 mg of RNase per ml, and then extracted with -5------0 '0 " phenol and assayed for infectious viral RNA. sackievirus A13 in the presence of RHB results from a loss in the ability of these virus particles to attach to susceptible cells.
Loss of VP4 from RHB-treated coxsackievirus A13. Several investigators (2, 3, 5, 12, 17) demonstrated that specific removal of the smallest structural polypeptide (VP4) of certain picornaviruses, without concomitant release or inactivation of the viral genome, renders the viruses noninfectious because of their inability to attach to susceptible cells. Our finding that RHB inactivation is also due to a failure of the virus to adsorb lead us to investigate the polypeptide profiles of PBS-and RHB-treated coxsackievirus A13.
Although two groups (5, 7) have investigated the protein composition of several group B coxsackieviruses, we are unaware of any reports dealing specifically with coxsackieviruses belonging to group A. Therefore, as controls for further experiments, the polypeptide profile of coxsackievirus A13 was analyzed in comparison to type 1 poliovirus. Purified preparations of 3H-labeled amino acid-labeled coxsackievirus A13 and "4C-labeled protein hydrolysatelabeled type 1 poliovirus were mixed and subjected to disruption and SDS-polyacrylamide gel electrophoresis. The only significant difference noted (Fig. 2) between the two viruses was that the capsid protein of coxsackievirus A13 is routinely resolved into five distinct components, whereas separation of poliovirus into more than four polypeptides (VP1, VP2, VP3, and VP4) was never observed under these conditions of electrophoresis. We have tentatively designated the two coxsackievirus polypeptides, which migrate slightly faster than VP2 of polivirus, as VP2a and VP2b. With the molecular weights of the polypeptides of poliovirus reported by Maizel and Summers (15) as internal standards, and by plotting the log of the molecular weight of the polypeptides against fraction number, the molecular weights of the coxsack- ievirus polypeptides were calculated to be: VP1, 36,000; VP2a, 27,000; VP2b, 25,500; VP3, 21,500; and VP4, approximately 7,000.
To determine the effect of low ionic strength on the structural polypeptide composition of coxsackievirus A13, purified "4C-labeled protein hydrolysate-labeled virus was diluted 1:50 into PBS or RHB and incubated at 37 C for 90 min. Five-milliliter samples of each were centrifuged in a Spinco SW65 rotor at 179,000 x g for 2.5 h. The pellets and supernatants were then separated by the following procedure for subsequent analysis on SDS-gels. The upper 4.5 ml of each supernatant was carefully removed and saved. The remaining 0.5 ml of the supernatants were discarded, and the pellets (virus pellets) were suspended in 0.2 ml of 0.01 M sodium phosphate buffer (pH 7.2) and dialyzed overnight at 4 C against the same buffer. One milligram of bovine serum albumin and an equal volume of cold 10% trichloroacetic acid were added to each supernatant. After 1 h at 4 C, the supernatants were centrifuged at 900 x g for 10 min, and the pellets (trichloroacetic acid precipitates) were rinsed twice with cold 5% trichloroacetic acid, resuspended in 0.5 ml of 0.01 M sodium phosphate buffer (pH 7.2), and dialyzed overnight at 4 C against the same buffer. The virus pellets and trichloroacetic acid precipitates were then solubilized and subjected to electrophoresis.
The polypeptide profiles of the virus pellets from PBS-and RHB-treated preparations were determined on separate gels, but are plotted together in Fig. 3 . These data reveal that the only detectable alteration in those virions that are sedimentable after RHB inactivation is the specific loss of the minor structural polypeptide VP4, suggesting that the inability of inactivated virus to attach to cells is directly correlated with the loss of VP4. If VP4 is dissociated during RHB inactivation, it should be recoverable from the nonsedimentable material in the RHB supernatants. Accordingly, the trichloroacetic acid precipitates of PBS and RHB supernatants were electrophoresed on separate gels, and the combined data are presented in Fig. 4 . The electrophoretic profiles show that the only virion polypeptide present in significant amounts in the nonsedimentable fraction of RHB-inactivated virus is VP4, and that VP4 can be recovered by trichloroacetic acid precipitation provided the inactivated viral particles are first removed by centrifugation. These results provide additional evidence which supports the premise that RHB induces the specific loss of VP4 from the capsid of coxsackievirus A13.
DISCUSSION
Release of RNA from virions of group A coxsackieviruses would account a priori for the loss of infectivity that occurs in hypotonic RHB at neutral pH (Fig. 1) . However, a comparison of the amount of infectious RNA extractable from control and RHB-treated virus (Table 1) indicates that more than one-half of the inactivated particles contain RNA in an essentially normal state, judged by the fact that infectivity of the RNA remains insensitive to the action of RNase. Therefore, it is unlikely that inactiva-700 600r 500 0400-tion under these conditions is entirely due to degradation or release of viral nucleic acid. In fact, a preliminary experiment (unpublished data) has shown that greater than 90% of 3H-labeled amino acid-labeled, RHB-inactivated particles sediment in sucrose gradients at a rate only slightly slower than that of intact virions (150 S) and little or no radioactivity can be detected in these gradients in the position that empty capsids (80 S) would be expected to band. These results suggest that most, if not all, RHB-inactivated particles contain viral RNA.
RHB-inactivated virions are unable to adsorb to susceptible cells (Table 2) , and this finding provides an explanation for the previous observation that RHB-treated virus is not infectious, in spite of the fact that it contains a relatively normal complement of infectious RNA. Furthermore, the finding that VP4 is specifically dissociated from coxsackievirions during inactivation with RHB ( Fig. 3 and 4 The results shown in Fig. 2 reveal that coxsackievirus A13 is composed of five structural polypeptides which have been designated VP1, VP2a, VP2b, VP3, and VP4. To our knowledge, this is the first report dealing with the electrophoretic profile of group A coxsackieviruses. It is interesting to note that no more than four polypeptides have been detected in the closely related group B coxsackieviruses (5, 7) .
Although picornaviruses are generally considered to contain four major size classes of structural proteins, recent evidence has shown that at least three of the capsid polypeptides (VP1, VP2, and VP3) of several poliovirus strains can be resolved into two or three subcomponents (4, 19, 22) . Therefore, electrophoretic profiles of these viruses show from five to seven bands, depending upon the strain. Cooper et al. (4) have postulated that subcomponents of a given virion polypeptide are formed as a result of alternate cleavage sites in the larger proteins which serve as precursors to the final polypeptide products.
The nature of VP2a and VP2b of coxsackievirus A13 (Fig. 3) is not clear at the present time. First, the virus used in these studies had undergone several passages subsequent to plaque purification and, therefore, the data do not exclude the presence of a mutant containing a genetically altered VP2. Secondly, it is possible, due to alternating cleavages of VPO (the precursor to VP2, reference 9) at two sites during maturation (4, 19) , that two types of particles are formed, one containing VP2a, the other VP2b. Finally, if two sites on VPO were cleaved simultaneously (19, 22) , all virions produced would be composed of five polypeptides, including both VP2a and VP2b. The data do not distinguish between these three possibilities.
Although VP2a and VP2b of type 1 poliovirus differ in molecular weight by 2,500 to 3,000 (4, 19) , we have been unable to resolve these polypeptides by using the same strain (Mahoney), even under electrophoretic conditions in which the two analogous components of coxsackievirus A13, which have an even smaller diversity in molecular weight, can be separated (Fig. 2) . It is possible that the differences in the sizes and numbers of picornavirus structural polypeptides that have been reported by various laboratories may depend to a greater extent than previously expected on the passage history of the virus, the host cells, or on other conditions of the culture system being used. Further investigation into these possibilities would seem to be warranted.
